The Association between Circulating Secreted Protein Acidic and Rich in Cysteine (SPARC) and Glycosylated Haemoglobin (HbA 1c ) during Lifestyle-Modified Weight Reduction Intervention in Obese Male Subjects

Abstract

The physiological role and clinical relevance of circulating secreted protein acidic and rich in cysteine (SPARC, or osteonectin) is still poorly understood. This study investigated the correlation between circulating SPARC and metabolic variables, including glucose and glycosylated haemoglobin (HbA_1c), during a diet and exercise modified weight reduction intervention programme. Changes in plasma SPARC levels and several metabolic variables were analysed in asymptomatically obese, nondiabetic, male subjects before and after weight reduction intervention. Body mass index and blood pressure, serum cholesterol and HbA_1c levels were all significantly reduced after weight reduction intervention. Multiple regression analysis demonstrated that changes in SPARC levels were significantly and positively correlated with HbA_1c. The relationship between SPARC and HbA_1c may merit further investigation with regard to its association with postprandial or long-term glucose variation in obese male subjects.

Keywords

Secreted protein acidic and rich in cysteine SPARC Osteonectin Glucose metabolism Body mass index Obesity Weight loss

References

Sheard

: Moderate changes in weight and physical activity can prevent or delay the development of type 2 diabetes mellitus in susceptible individuals. Nutr Rev 2003; 61: 76–79.

Aronne

Isoldi

: Overweight and obesity: key components of cardiometabolic risk. Clin Cornerstone 2007; 8: 29–37.

Tartare-Deckert

Chavey

Monthouel

: The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 2001; 276: 22231–22237.

Takahashi

Nagaretani

Funahashi

: The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. Obes Res 2001; 9: 388–393.

Kanauchi

Nishioka

Dohi

: Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury. Diabetologia 2000; 43: 1076–1077.

Watanabe

Okamoto

Yokoo

: SPARC is a major secretory gene expressed and involved in the development of proliferative diabetic retinopathy. J Atheroscler Thromb 2009; 16: 69–76.

Stolar

: Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010; 123 (3 suppl): S3–S11.

Nesto

Nelinson

Pagotto

: Guiding clinical decisions on abdominal obesity and cardiometabolic risk. Clin Cornerstone 2009; 9: 43–54.

Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity: New criteria for ‘obesity disease’ in Japan. Circ J 2002; 66: 987–992.

10.

Japan Atherosclerosis Society: Japan Atherosclerosis Society Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases. Tokyo: Japan Atherosclerosis Society, 2002 [in Japanese].

11.

Scheen

Paquot

Letiexhe

: Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies. Int J Obes Relat Metab Disord 1995; 19 (suppl 3): S14–S20.

12.

Gerich

: Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003; 163: 1306–1316.

13.

Gong

Yang

: The association of dysglycaemia and cardiovascular disease in patients with metabolic syndrome. J Int Med Res 2009; 37: 1486–1492.